IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1231
Positioning
Market Dominance
Manufacturing
Chemicals
$7.2B
Mark J. Costa
Eastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, cellulose esters, polyvinyl butyral (PVB) sheets, and window and protective films.
Headcount
14.5K
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = EMN ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 32.9% | 20.5% | 48.8% | 30.6% | 24.4% | 7.7% | 0.9% | 32.0x | $148.6B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.4% | 7.5% | 68.3% | 19.5% | 18.2% | 29.0% | 0.0% | 0.0x | $84M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$EMN EASTMAN CHEMICAL CO | 55 | 53 | 81 | 43 | 16.4x | 6.3x | 9.1% | 3.7% | 22.8% | 11.2% | 5.9% | -6.8% | 5.3% | 146.0x | $7.2B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -1.9% | 0.9% | 44.1% | 2.5% | 1.0% | 6.7% | 0.0% | 0.2x | - | REF |
EASTMAN CHEMICAL CO (EMN) receives a "Hold" rating with a composite score of 55.3/100. It ranks #1231 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
HQ Base
Kingsport, Tennessee
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for EMN.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 53 | 49 | +4NEUTRAL |
| MOMENTUM | 43 | 34 | +9ALPHA |
| VALUATION | 81 | 85 | -4NEUTRAL |
| INVESTMENT | 33 | 53 | -20DRAG |
| STABILITY | 65 | 63 | +2NEUTRAL |
| SHORT INT | 55 | 64 | -9DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 14.7% vs WACC 6.6% (spread +8.2%)
GM 23% vs sector 44%, OM 11% vs sector 3%
Capital turnover 1.91x, R&D intensity 2.9%
Rev growth -7%, 10yr history
Interest coverage 14.4x, Net debt/EBITDA 3.6x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate EASTMAN CHEMICAL CO (EMN) as a Hold with a composite score of 55.3/100 at a current price of $77.15. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling.
EASTMAN CHEMICAL CO holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 55.3/100 places it at rank #1231 in our full universe.
Narrow
High
Poor
Undervalued
Value factor score of 81 suggests attractive pricing.
Stable competitive position in a defensive sector.
Leverage of 146% D/E amplifies downside risk.
Vulnerability to macroeconomic shocks and interest rate volatility.
EASTMAN CHEMICAL CO represents a hold based on multi-factor quantitative performance.
Our model assigns EASTMAN CHEMICAL CO a Hold rating, with a composite score of 55.3/100 and 3 out of 5 stars. Ranked #1231 of 7,333 stocks, EMN presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 53/100, EMN shows adequate but unremarkable business quality. The company reports a return on equity of 9.1% (sector avg: -1.9%), gross margins of 22.8% (sector avg: 44.1%), net margins of 5.9% (sector avg: 1.0%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
EMN carries a solid value score of 81/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 16.38x, an EV/EBITDA of 6.34x, a P/B ratio of 1.50x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
EASTMAN CHEMICAL CO's investment score of 33/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -6.8% vs. a sector average of 6.7% and a return on assets of 3.7% (sector: 0.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
EMN is currently showing below-average momentum at 43/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at -6.8% year-over-year, while a beta of 1.26 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
EMN shows good financial stability with a score of 65/100. Key stability metrics include a beta of 1.26 and a debt-to-equity ratio of 146.00x (sector avg: 0.2x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
The short interest score of 55/100 for EMN suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include above-average market sensitivity (beta: 1.26), elevated leverage (D/E: 146.00x). With a $7.2B market cap (mid-cap), EASTMAN CHEMICAL CO may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
EASTMAN CHEMICAL CO offers an attractive dividend yield of 5.3%, placing it among the higher-yielding stocks in its peer group. A yield this high can provide meaningful income, but investors should verify the payout is sustainable by examining the payout ratio, free cash flow coverage, and any history of dividend cuts.
EASTMAN CHEMICAL CO is a mid-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1231 of 7,333 overall (83rd percentile). Key comparisons include ROE of 9.1% exceeding the -1.9% sector median and operating margins of 11.2% above the 2.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While EMN currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Value (81) vs Investment (33) — closing this gap could shift the rating.
EV/EBITDA 45% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 581% BELOW SECTOR MEDIAN
Gross Margin 48% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
In February 2026, Eastman Chemical Company completed a US$598.72 million fixed-rate senior unsecured notes offering due 2031, while its board affirmed a quarterly cash dividend of US$0.84 per share payable in April and confirmed completion of a multi-year US$3,155.42 million share repurchase program initiated in 2018. The company’s ability to fund itself through the bond market, maintain a long-running dividend stream, and finish a sizeable buyback highlights how its capital allocation...
The global polymers market size is estimated at USD 885.38 billion in 2026 and is expected to be worth around USD 1,424.98 billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.43 % over the forecast period from 2026 to 2035. A study published by Towards Chemical and Materials a sister firm of Precedence Research.Ottawa, Feb. 23, 2026 (GLOBE NEWSWIRE) -- According to Towards Chemical and Materials, the global polymers market size was valued at USD 839.78 billion in 2025 and is ex
Dow Inc. is experiencing significant market challenges, cutting its dividend by 50% and reducing capital expenditures to survive a prolonged industry downturn characterized by low demand, supply chain disruptions, and intense global competition.
For Leah Martin, a 48-year-old attorney and mother, running on three to five hours of sleep felt normal until headaches and fatigue made her realize she wasn’t performing at her best. “I wasn’…